Lala Salim, Knowles Martyn, Timaran David, Baig Mirza Shadman, Valentine James, Timaran Carlos
Division of Vascular Surgery, University of Texas Southwestern Medical Center, Dallas, Tex.
Division of Vascular Surgery, University of North Carolina, Chapel Hill, NC.
J Vasc Surg. 2016 Sep;64(3):692-7. doi: 10.1016/j.jvs.2016.02.031. Epub 2016 Jun 8.
The Zenith (Cook Medical, Bloomington, Ind) fenestrated endovascular graft may be designed with single-wide scallops or large fenestrations to address the superior mesenteric artery (SMA). Misalignment of the SMA with an unstented scallop or a large fenestration is possible. This study assessed SMA outcomes after fenestrated endovascular aortic aneurysm repair (FEVAR).
During an 18-month period, 47 FEVARs were performed at a single institution. For analysis, patients were grouped according to unstented (n = 23) vs stented (n = 24) SMA scallops/fenestrations. The Institutional Review Board approved this single-institution observational study. Because this was a retrospective review of the data, patient consent was unnecessary for the study.
Technical success for FEVAR was 100%. The median follow-up period was 7.7 months (range, 1-16 months). Nine of 21 patients (43%) in the unstented group had some degree of misalignment of the SMA (range, 9%-71%). Among these, four patients (44%) developed complications: three SMA stenoses and one occlusion. The mean peak systolic velocity in patients with and without SMA misalignment was 317.8 cm/s vs 188.4 cm/s (P < .08), respectively. No misalignment occurred in the stented group, and only one of 19 patients (5%) developed an SMA stenosis that required angioplasty. Overall, patients with unstented SMAs had significantly more adverse events directly attributable to SMA misalignment than the stented group (44% vs 5%, respectively; P < .05).
Misalignment of the SMA with the use of unstented unreinforced scallops or fenestrations occurs frequently. Routine stenting of single-wide and large fenestrations, when feasible, may be a safer option for patients undergoing FEVAR.
Cook Medical公司(位于印第安纳州布卢明顿)生产的Zenith开窗型血管内移植物可设计为单宽扇贝形或大开窗,以处理肠系膜上动脉(SMA)。SMA与无支架扇贝形或大开窗可能会出现错位。本研究评估了开窗型血管内主动脉瘤修复术(FEVAR)后SMA的情况。
在18个月期间,在单一机构进行了47例FEVAR手术。为进行分析,根据无支架(n = 23)与有支架(n = 24)的SMA扇贝形/开窗情况对患者进行分组。机构审查委员会批准了这项单一机构观察性研究。由于这是对数据的回顾性审查,该研究无需患者同意。
FEVAR的技术成功率为100%。中位随访期为7.7个月(范围1 - 16个月)。无支架组21例患者中有9例(43%)存在一定程度的SMA错位(范围9% - 71%)。其中,4例患者(44%)出现并发症:3例SMA狭窄和1例闭塞。有SMA错位和无SMA错位患者的平均收缩期峰值流速分别为317.8 cm/s和188.4 cm/s(P < 0.08)。有支架组未出现错位,19例患者中只有1例(5%)发生了需要血管成形术的SMA狭窄。总体而言,无支架SMA的患者因SMA错位直接导致的不良事件明显多于有支架组(分别为44%和5%;P < 0.05)。
使用无支架、无加强的扇贝形或开窗时SMA错位经常发生。对于接受FEVAR的患者,在可行的情况下,对单宽和大开窗进行常规支架置入可能是更安全的选择。